Subcutaneous sumatriptan for the treatment of postcraniotomy pain (SUPS trial): protocol for a randomised double-blinded placebo controlled trial

INTRODUCTION: Postcraniotomy pain protocols use opioids, which are considered suboptimal analgesia following this procedure. Multimodal analgesia components are sparse. Our null hypothesis states that sumatriptan is not different to placebo in addition to usual intravenous opioids, for the treatment...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMJ Open
Päätekijät: Licina, Ana, Russell, Jeremy, Silvers, Andrew, Jin, Xin, Denny, Jason
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Publishing Group 2019
Aiheet:
Anaesthesia
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6701595/
https://ncbi.nlm.nih.gov/pubmed/31427345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2019-032388
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia